Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;36(3):621-629.
doi: 10.1007/s00467-020-04744-8. Epub 2020 Sep 19.

Therapeutic plasma exchange: single-center experience in children with kidney disorders

Catherine Joseph  1 , Sahar Siddiqui  2 , Shweta Shah  2 , Catharina H Solomon  2 , Poyyapakkam R Srivaths  2
Affiliations

Therapeutic plasma exchange: single-center experience in children with kidney disorders

Catherine Joseph et al. Pediatr Nephrol. 2021 Mar.

Abstract

Background: Therapeutic plasma exchange (TPE) is used in kidney diseases as an adjunct treatment. Little has been described as to its effectiveness in kidney disorders in children. This study aimed to assess the safety, efficacy, and outcomes of patients who underwent TPE for kidney indications.

Methods: Retrospective chart review of patients receiving TPE from 2010 to 2018 for kidney indications, such as antibody-mediated rejection, bone marrow transplant-associated thrombotic microangiopathy (TA-TMA), atypical hemolytic uremic syndrome, transplant recurrence of focal segmental glomerulosclerosis, and glomerulonephritis. Outcomes assessed were trends in kidney function, mortality, and progression to stage 5 chronic kidney disease (CKD 5). Significant hypocalcemia was defined as ionized calcium < 1 mmol/L.

Results: A total of 641 TPE procedures were performed on 47 patients (25 male). Average age was 12.8 ± 5.9 years. Median glomerular filtration rate (GFR) improved from baseline to end of TPE treatments (pre 44.9 (19.8, 79), end 56.1 (23, 98) [p = 0.02]). Ten out of 47 children developed CKD 5. Seven out of 47 patients died; 5 had TA-TMA. Initial 7 consecutive sessions were reviewed for complications. Among 335 procedures, 41 episodes of significant hypocalcemia were noted (12.2%); only 1 was symptomatic. Of the 26 episodes (7.7%) of allergic reactions, all were associated with the use of FFP; 5 were anaphylactic. No TPE-associated mortality was noted.

Conclusions: TPE is a relatively well-tolerated useful adjunct therapy in children with kidney indications. The benefit of TPE has to be balanced with risks such as hypocalcemia and allergic reactions which can occur more frequently with FFP. Graphical abstract.

Keywords: Children; Efficacy; Kidney; Outcomes; Pediatrics; Plasmapheresis; Safety.

PubMed Disclaimer

References

    1. Kaplan AA (2013) Therapeutic plasma exchange: a technical and operational review. J Clin Apher 28:3–10 - DOI
    1. Kaplan AA (2008) Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis 52:1180–1196 - DOI
    1. Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK (1975) Recovery from Goodpasture’s syndrome after immunosuppressive treatment and plasmapheresis. Br Med J 2:252–254 - DOI
    1. Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB (1976) Immunosuppression and plasma-exchange in the treatment of Goodpasture’s syndrome. Lancet 1:711–715 - DOI
    1. Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ (2019) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher 34:171–354 - DOI

LinkOut - more resources